Rademaker B, Kramer K, van Ingen H, Kranendonk M, Timmerman H
J Recept Res. 1985;5(2-3):121-31. doi: 10.3109/10799898509041874.
The fluorescent beta-adrenergic receptor probe alprenolol-NBD was found to exhibit a high affinity (Kd 3.2 nM) and a low capacity (10 fmol/mg protein) for the beta 2-adrenergic receptor on living Chang liver cells but also a high affinity (Kd 320 nM) for non-beta-adrenergic receptor binding sites with a very high capacity (28,000 fmol/mg protein). Calculations are presented which make clear that less than 3% of the binding of alprenolol-NBD during visualization experiments is beta-adrenergic receptor related. Furthermore, it is shown that besides the downregulation of beta-adrenergic receptors during incubation with isoproterenol, the high-affinity non-beta-receptor binding sites are also deminishing during incubation with isoproterenol. Based on our findings it is concluded that the results of Henis et al. who claimed the visualization of the beta-adrenergic receptor population on Chang liver cells by alprenolol-NBD must be interpreted as an almost completely non-specific fluorescence.
荧光β-肾上腺素能受体探针阿普洛尔-NBD被发现对活的张氏肝细胞上的β2-肾上腺素能受体具有高亲和力(解离常数Kd为3.2 nM)和低容量(10 fmol/mg蛋白质),但对非β-肾上腺素能受体结合位点也具有高亲和力(Kd为320 nM),且容量非常高(28,000 fmol/mg蛋白质)。所呈现的计算结果表明,在可视化实验期间,阿普洛尔-NBD的结合中与β-肾上腺素能受体相关的不到3%。此外,研究表明,除了在与异丙肾上腺素孵育期间β-肾上腺素能受体下调外,在与异丙肾上腺素孵育期间,高亲和力非β受体结合位点也在减少。基于我们的发现,得出结论:赫尼斯等人声称通过阿普洛尔-NBD可视化张氏肝细胞上β-肾上腺素能受体群体的结果必须被解释为几乎完全是非特异性荧光。